Skip to content

Novel TB regimen could reduce treatment duration

Mel Spigelman and Dan Everitt  presenting at AIDS 2014. Photo by Liz Highleyman, hivandhepatitis.com

Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant women

Study finds no evidence that HIV-positive gay men in UK have increased risk of neurocognitive impairment

HIV/HCV co-infection associated with increased risk of osteoporosis and fractures

Complex needs and overlapping vulnerabilities frequently reported by 'high-risk' gay men in Scotland

Protease inhibitor therapy increases underlying genetic risk of diabetes for women with HIV

Men living with HIV have a lower risk of prostate cancer

Tenofovir HIV PrEP causes no long-term harm to kidneys

Action needed to tackle co-infection with HIV and visceral leishmaniasis in India